ADHESION MOLECULE TARGETED THERAPY FOR NON-INFECTIOUS UVEITIS INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022; 23: 503-503 陳怡杏 SUE MALIHE VIRGINIA*
CD4+ T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease Int J Mol Sci. 2021 Sep 3;22(17):9584. o Chen YH, Lightman S, Calder VL.
Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis. J Neuroinflammation. 2021 Feb 18;18(1):49 Chen YH, Eskandarpour M, Zhang X, Galatowicz G, Greenwood J, Lightman S, Calder V.
Leukotriene B4 and Its Receptor in Experimental Autoimmune Uveitis and in Human Retinal Tissues: Clinical Severity and LTB4 Dependence of Retinal Th17 Cells. Am J Pathol. 2021 Feb;191(2):320-334. Eskandarpour M, Chen YH, Nunn MA, Coupland SE, Weston-Davies W, Calder VL.
Prospective study of morphologic and functional parameter changes post intravitreal therapy for macular edema. Graefes Arch Clin Exp Ophthalmol. 2020 Sep;258(9):1941-1947. Sharief L, Chen YH, Lightman S, Tomkins-Netzer O.
Functionally Distinct Th17/Th1 (IFNγ+IL-17A+) cells in experimental autoimmune uveitis (EAU): T cell heterogeneity, plasticity and steroid response. Eur J Immun. 2020. Dec;50(12):1941-1951. Chen YH, Eskandarpour M, Gondrand A, Zhang, X, Gu R, Galatowicz G, Lightman S, Calder V.